[1] Gerber Y, Vanwagner LB, Yaffe K, et al.Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: The CARDIA study[J]. BMC Gastroenterol,2021,21(1):96-104. [2] Li J, Zou B, Yeo YH, et al.Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol,2019,4(5):389-398. [3] Huang DQ, El-Serag HB, Loomba R.Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention[J].Nat Rev Gastroenterol Hepatol,2021,18(4):223-238. [4] Zhang Y, Xu R, Ai L, et al.Association between non-alcoholic fatty liver disease and silent carotid plaque in Chinese aged population: A cross-sectional study[J].Ann Palliat Med,2020,9(2):182-189. [5] Younossi ZM, Koenig AB, Abdelatif D, et al.Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J]. J Hepatol,2016,64(1):73-84. [6] Younossi ZM.Non-alcoholic fatty liver disease-A global public health perspective[J]. J Hepatol,2019,70(3):531-544. [7] Estes C, Anstee QM, Arias-Loste MT, et al.Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol,2018,69(4):896-904. [8] 夏祖宇,黄夕夏,熊文坚,等.上海市某社区老年人非酒精性脂肪性肝病患病率及危险因素分析[J].老年医学与保健,2021,27(5):987-993. [9] 朱瑞华,何展明,陈清.广州市某社区老年人非酒精性脂肪肝患病状况及危险因素分析[J].热带医学杂志,2021,21(6):803-806. [10] Ascha MS, Hanouneh IA, Lopez R, et al.The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis[J]. Hepatology,2010,51(6):1972-1978. [11] Pan JJ, Fallon MB.Gender and racial differences in nonalcoholic fatty liver disease[J]. World J Hepatol,2014,6(5):274-283. [12] Naugler WE, Sakurai T, Kim S, et al.Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production[J]. Science,2007,317(5834):121-124. [13] 孙海燕. 非酒精性脂肪肝患者血生化指标、饮食及行为特征研究[J].华南预防医学,2020,46(6):605-608. [14] 万红,燕树勋,闫诏,等.肥胖患者外周血miR-155表达与非酒精性脂肪肝病发病的关系[J].分子诊断与治疗杂志,2021,13(4):539-542. [15] Allen AM, Therneau TM, Larson JJ, et al.Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study[J]. Hepatology,2018,67(5):1726-1736. [16] Karajamaki AJ, Bloigu R, Kauma H, et al.Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes[J]. Metabolism,2017,66:55-63. [17] Kotronen A, Juurinen L, Tiikkainen M, et al.Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes[J]. Gastroenterology,2008,135(1):122-130. [18] Park H, Dawwas GK, Liu X, et al.Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: A propensity-matched cohort study[J]. J Intern Med,2019,286(6):711-722. [19] Mantovani A, Zaza G, Byrne C D, et al.Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis[J]. Metabolism,2018,79:64-76. [20] Buzas GM.Helicobacter pylori and non-alcoholic fatty liver disease[J]. Minerva Gastroenterol Dietol,2020,66(3):267-279. [21] Geier A, Tiniakos D, Denk H, et al.From the origin of NASH to the future of metabolic fatty liver disease[J].Gut,2021,70(8):1570-1579. [22] Alferink LJ, Kiefte-De JJ, Erler NS, et al.Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: The Rotterdam Study[J]. Gut,2019,68(6):1088-1098. [23] Drinda S, Grundler F, Neumann T, et al.Effects of periodic fasting on fatty liver index-A prospective observational study[J]. Nutrients,2019,11(11):2601-2614. |